| As of Thursday, November 12th: |
As of October 1st, the earnings growth rate was at -24.7%.Of the 458 S&P 500 companies who have reported Q3, 80% beat estimates, 6% were in-line, and 14% were below estimates. The blended earnings growth rate for the S&P 500 for Q3 2009 is currently at -13.9%. (Data provided by Thomson Reuters)
LATEST EARNINGS RESULTS
- Friday May See 'Risk Trade' Stalling; Dollar in Focus
- Job Market Politics to Keep Interest Rates Low
- AIG, Symbol of Crisis, Watches Its Stock Zoom Back
- Disney Profit, Sales Top Street Forecasts; Shares Jump
- Bill Gates Praises Apple's Jobs for 'Saving the Company'
- Cities With the Most Home Price Reductions
- Is Euphoric Market Ignoring Warning Signs?
- Video Game Sales Plunge, but Have They Hit Bottom?
- Despite Rhetoric, Obama Has Few Options to Boost Jobs
- EXCERPTS and IMAGES: Warren Buffett & Bill Gates - Keeping America Great
- Microsoft's Bill Gates Praises Apple's Steve Jobs For 'Saving the Company'
- Gold Is a Bad Inflation Hedge—Like Oil: Stock Picker
- Intel's Andy Bryant Offers An Explanation
- US 'Actively Working' on Weaker Dollar: Fund Manager
- Options Boil on Biotech Buyout Rumors
- Warren Buffett's $100,000 Offer and $500,000 Advice for Columbia Business School Students
- Activision Blizzard's "Modern Warfare 2" Sales Break Records
- 5-Star Manager's 5 Stocks for Changing Markets
MOST SHARED
- Warren Buffett and Bill Gates Share Their 'Optimism' With Eager Columbia Business Students
- Pharma & Social Media
- Cities With the Most Home Price Reductions
- China Fourth Quarter Growth Could Hit 10%: Official
- Disney Profit, Sales Top Street Forecasts; Shares Jump
- Microsoft's Bill Gates Praises Apple's Steve Jobs For 'Saving the Company'
- Warren Buffett's $100,000 Offer and $500,000 Advice for Columbia Business School Students
- Is Euphoric Market Ignoring Warning Signs?
- Disney CFO and Parks Chief to Swap Roles
Text Size 
Boston Scientific quarterly earnings fell 15 percent on declining sales of its drug-eluting stents and charges for acquisitions, divestitures and restructuring.
 |
Click for more earnings info |
Second-quarter net income was $98 million, or 7 cents a share, compared with net income of $115 million, or 8 cents a share, a year ago.
Excluding special items, Boston Scientific [BSX
Loading...
()
] said its second- quarter earnings were 20 cents a share.
On that basis, analysts on average had forecast a profit of 18 cents a share, according to Reuters Estimates.
Overall net sales in the second quarter fell about 2 percent to $2.02 billion, compared with $2.07 billion in the year-ago quarter.
The Natick, Massachusetts-based company said worldwide sales of its drug-releasing heart stents declined to $382 million in the second quarter from $437 million a year ago.
U.S. sales of drug-eluting stents were $175 million, down from $249 million.
Stents are small wire mesh tubes inserted into coronary arteries to prop them open after they have been cleared of blockages.
Worldwide sales of cardiac rhythm management devices rose to $578 million, including $420 million in sales of implantable cardioverter defibrillators, which correct abnormal heart rhythms.
CRM sales in last year's quarter were $524 million, including ICD sales of $377 million.
Boston Scientific forecast overall third-quarter sales of between $1.95 billion and $2.06 billion and income, excluding special items, of between 14 cents and 19 cents a share.
It estimated third-quarter net earnings would be between 18 cents and 23 cents a share.
Print
Email
- Nordstrom Earnings Miss Forecasts; Shares Take Hit
Nordstrom reported earnings that missed analysts expectations by a penny but beat on revenue, causing the company's shares to fall in after-hours trading.
- Wal-Mart Holiday Forecast Light, Profit Beats
Wal-Mart Stores posted a higher-than-expected quarterly profit, but forecast earnings during the key holiday quarter that could miss Wall Street estimates as its customers face rising unemployment.
- Kohl's Profit Beats Street, But Outlook Falls Short
Department store operator Kohl's Corp reported a larger-than-expected quarterly profit Thursday, but gave an outlook below Wall Street estimates for the period that includes the key holiday season.
- Nordstrom Earnings Miss Forecasts; Shares Take Hit
- Vivendi Profit Up More Than 5%, Keeps 2009 Goals
Europe's largest entertainment group Vivendi delivered a better than expected 5.1 percent rise in its third-quarter underlying profit on Thursday, and said it was sticking to its 2009 forecast.
- Vivendi Profit Up More Than 5%, Keeps 2009 Goals
- Cost Cuts Help BT to Raise Full-Year Guidance
- Applied Materials Profit, Sales Top Wall Street Forecasts
- Macy's Loss Beats Estimates, But Shares Fall on Outlook
- Vodafone Extends Cost-Cutting Scheme, Hits Targets
- Tyco International Profit Falls Less Than Expected
- EA Profit Beats Street, Announces Job Cuts
- Priceline Crushes Profit Forecasts; Shares Jump
- Berkshire Hathaway Says Net Income Tripled
- Sun Micro Sales Fall as Oracle Deal Remains Delayed
- AIG in the Black Again, Operating Profit Tops View
- Starbucks Profit Beats Forecasts; Shares Rise
- Fannie Mae Seeks $15 Billion in Aid After Posting Loss
- Nvidia Profit, Sales Top Wall Street's Forecast
- CBS Beats Expectations on Improved Ad Market
- Cisco CEO: Tech Sector Hit Bottom, Recovery Under Way
Data is a real-time snapshot *Data is delayed at least 15 minutes